FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.826
+0.093 (12.67%)
At close: Jun 26, 2026, 4:00 PM EDT
0.851
+0.024 (2.95%)
After-hours: Jun 26, 2026, 7:59 PM EDT
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,245,333
Market Cap
4.46M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| TransCode Therapeutics | 12 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| 60 Degrees Pharmaceuticals | 3 |
| Matinas BioPharma Holdings | 2 |
FBLG News
- 1 day ago - FibroBiologics announces $9M private placement priced at-the-market - TheFly
- 1 day ago - FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - PRNewsWire
- 5 days ago - FibroBiologics Transcript: AGM 2026 - Transcripts
- 5 days ago - FibroBiologics receives notice of allowance for U.S. patent - TheFly
- 5 days ago - FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing - GlobeNewsWire
- 11 days ago - FibroBiologics doses first patients in CYWC628 clinical trial - TheFly
- 11 days ago - FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers - GlobeNewsWire
- 24 days ago - FibroBiologics doses first patients in CYWC628 trial - TheFly